Abstract: The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
Type:
Application
Filed:
September 28, 2007
Publication date:
January 21, 2010
Applicant:
Actelion Phamaceuticals Ltd.
Inventors:
Hamed Aissaoui, Christoph Boss, Markus Gude, Ralf Koberstein, David Lehmann, Thierry Sifferlen, Daniel Trachsel